National Institute of Allergy and Infectious Diseases, National Institutes of Health - March 14, 2007

The council provides recommendations on the conduct and support of research, including training young scientists and disseminating health information derived from NIAID research. It embodies a diverse perspective on science, health and the human impact of disease. The council is composed of physicians, scientists and representatives of the public who contribute their time and expertise for a four-year term.

The new council members are Robert Brooks, M.D., of the Florida State University College of Medicine; Satya Dandekar, Ph.D., from the University of California, Davis; Sharon C. Kiely, M.D., M.P.H., of Allegheny General Hospital in Pittsburgh and Drexel University School of Medicine; Marc E. Rothenberg, M.D., Ph.D., from the Cincinnati Children's Hospital Medical Center; and David S. Wilkes, M.D., of the Indiana University School of Medicine.

Robert Brooks, M.D., is associate dean for health affairs and professor of family medicine and rural health at the Florida State University College of Medicine in Tallahassee. He serves on the Florida Governor's Health Information Technology Advisory Board and the Florida Medicaid Reform Advisory Council. Previously, he was chief of infectious diseases at the Orlando Regional Medical Center. He served in the Florida House of Representatives from 1994 until late 1998 when he was appointed Secretary of the Florida Department of Health.

Satya Dandekar, Ph.D., is professor and chair, Department of Internal Medicine, University of California, Davis. Her expertise and research interests are in the areas of HIV/AIDS. She has participated in the review of grant applications and program projects for several NIH committees and has been a scientific reviewer for numerous journals and boards. She also has been invited to lecture on clinical infectious diseases for professional organizations.

Sharon C. Kiely, M.D., M.P.H., is medical director for quality and patient safety at Allegheny General Hospital in Pittsburgh and associate professor of medicine at Drexel University School of Medicine in Philadelphia. She has served on the United Network for Organ Sharing board of directors as well as the HHS Secretary's Advisory Committee on Xenotransplantation. She is a specialist in internal medicine and has focused her clinical, research and volunteer efforts on juvenile diabetes, medical education and care to underserved populations, including those with HIV/AIDS.

Marc E. Rothenberg, M.D., Ph.D., is professor of pediatrics and director of the Division of Allergy and Immunology at Cincinnati Children's Hospital Medical Center. He also serves as director for the Cincinnati Center for Eosinophilic Disorders. His research focuses on molecular mechanisms of allergic inflammation. He studies the genes and molecules involved in allergic responses, cellular and molecular immunology, and the development and analysis of genetically engineered and antigen-driven models of allergic disease in mice. He also conducts translational clinical trials.

David S. Wilkes, M.D., is Dr. Calvin H. English Professor of Medicine, Microbiology and Immunology at the Indiana University School of Medicine in Indianapolis. A pulmonary and critical care physician, he is also the director for the Center for Immunobiology at Indiana. He researches the immunopathogenesis of lung transplant rejection with a focus on alloimmune-induced autoimmunity in lung transplant recipients. Dr. Wilkes has served as a NIH study section member and co-chaired the NIH-sponsored workshop on Lung Transplantation: Opportunities for Research and Clinical Advancement.

NIAID is a component of the National Institutes of Health. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on basic immunology, transplantation and immune-related disorders, including autoimmune diseases, asthma and allergies.

The National Institutes of Health (NIH)--The Nation's Medical Research Agency--includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

###

News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at <http://www.niaid.nih.gov>.

070314
NI070304

Published 2007 - National Institute of Allergy and Infectious Diseases . All material contained in this report is in the public domain and may be used and reprinted without special permission; citation to source, however, is appreciated.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, the Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .